Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 801–850 of 34667
effective May 15, 2026, Mr. George Oliva resigned from the Board and any committees of the Board to which he belonged, which resignation was not the result of any disagreements with the Company relating to the Company’s operations, policies or practices; however Mr. Oliva continued as an officer of the Company as Chief Accounting Officer.
effective May 15, 2026, Messrs. Gene Jones and Tod Browndorf, resigned from the Board and any respective committees of the Board to which they belonged, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices .
On May 20, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Xometry, Inc. (the “Company”) appointed Lukas Biewald to serve as a member of the Board effective as of the Effective Date.
On May 19, 2026, the Board unanimously appointed Anthony Bowers to fill the director vacancy created by Mr. Titterton’s resignation.
On May 15, 2026, Mr. Lewis Titterton resigned from the Board of Directors (the “Board”) of ParkerVision, Inc. (the "Company"), and from the Audit and Compensation Committees on which he served.
On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.
On May 17, 2026, the Board appointed Zhong Li to serve as an independent director of the Company, effective as of May 18, 2026.
Effective May 18, 2026, Ningrong Liu resigned from the Board of Directors (the “Board”) of Chenghe Acquisition III Co. (the “Company”).
Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).
Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).
On May 14, 2026, the BayFirst Financial Corp. (the “Company”) received the non-objection of the Federal Reserve Bank of Atlanta, to appoint Alfred (“Al”) T. Rogers, Jr. to serve as the Company’s President and Chief Executive Officer, principal executive officer, and as a member of its Board of Directors.
On May 18, 2026, in connection with the IPO, Ms. Rakhi Kumar, Mr. Brad Middlekauff, and Mr. Patrick Crutcher (the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 18, 2026, in connection with the IPO, Ms. Rakhi Kumar, Mr. Brad Middlekauff, and Mr. Patrick Crutcher (the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 18, 2026, in connection with the IPO, Ms. Rakhi Kumar, Mr. Brad Middlekauff, and Mr. Patrick Crutcher (the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
elected a new director, John Livingston, to serve on the Board effective May 19, 2026
On May 19, 2026, the Compensation Committee granted Brent Pfeiffenberger the following initial equity awards under the Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Incentive Plan (the “2024 Plan”) in connection with his appointment to the Board
appointed Glenn Wright to serve as an independent director, effective May 26, 2026
On that date, the Board filled the additional Board seat by electing E. Morgan Flatley to serve as a member of the Board effective immediately.
On May 20, 2026, the Board of Directors (the “ Board ”) of Chiron Real Estate Inc. (the “ Company ”) approved an increase in the number of directors constituting the Board from six to seven directors and appointed Charles Fitzgerald to serve as a director of the Company, effective as of the same day, to serve until the Company’s 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.
the Company’s Board of Directors, upon recommendation of the Nominating and Corporate Governance Committee, appointed Rachael Wagner to the Board of Directors effective May 20, 2026.
Andres Small, a Class I director, gave notice of his resignation from the Board of Directors of Life Time Group Holdings, Inc. (the “Company”) effective May 20, 2026.
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On May 20, 2026, our board of directors approved an increase to the size of the board from twelve to thirteen members and appointed Luke Wood to fill the newly created vacancy.
In connection with Mr. Rahim’s resignation from the Board and transition from his Chief Financial Officer role, effective May 18, 2026, David R. Wells was appointed as a member of the Company’s Board and as the Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Company pursuant to a unanimous written consent approved by the Board on May 19, 2026.
On May 17, 2026, Tariq Rahim submitted his letter of resignation as a member of the Board of Directors (“Board”) of Functional Brands Inc. (the “Company”), effective immediately.
On May 20, 2026, in connection with the execution of the Stock Repurchase Agreement, Mr. Vikram Shankar resigned as a member of the Company’s Board of Directors, with such resignation being effective as of the Closing Date and being subject to the closing of the Share Repurchase.
On May 14, 2026, Mike Sayama, an independent director of SBC Medical Group Holdings Incorporated (the “Company”), notified the Company that he would not seek re-election at the Company’s forthcoming 2026 Annual Meeting of Stockholders (the “2026 AGM”).
On May 14, 2026, the board of directors (the “Board”) of Conduent Incorporated (the “Company”) elected Adam Demuyakor, Founder and Managing Partner of Wilshire Lane Capital, to the Board, effective June 1, 2026.
On May 18, 2026, J. Carney Hawks was removed from the Board of Directors (the “Board”) of Ferrellgas, Inc., the general partner (the “General Partner”) of Ferrellgas Partners, L.P. and Ferrellgas, L.P. (collectively, the “Company”).
Other than with respect to the matters described in Item 1.01 of this Current Report on Form 8-K, there is no arrangement or understanding between Mr. Jaffer and any other person pursuant to which he was selected as a director.
On May 18, 2026, Joseph Zwillinger, a director and co-founder of the Company's footwear business, notified the Board of Directors (the “Board”) of Allbirds, Inc. (the “Company”) of his intention to resign from the Board, effective as of May 18 2026.
On May 15, 2026, the Board increased the size of the Board from four to five members, and appointed Kevin Cameron, the Company’s Chief Executive Officer, to the Board as a Class III director, effective immediately.
On May 15, 2026, David Landskowsky tendered his resignation as a member of the board of directors (“Board”) of Ionetix Corporation (the “Company”), effective as of May 15, 2026.
On May 15, 2026, the Board appointed Michael Tarnok to the Board as a Class II director, effective as of May 18, 2026.
On May 19, 2026, the Board of Directors (the “Board”) of Newton Golf Company, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Gregg Hemphill as a director, effective May 19, 2026.
The resignation of Mr. Roscoe and Mr. Parekh and their resignation from the Company’s board of directors and all applicable committees thereof became effective on May 19, 2026.
The resignation of Mr. Roscoe and Mr. Parekh and their resignation from the Company’s board of directors and all applicable committees thereof became effective on May 19, 2026.
The Board also elected Mr. Wright to serve as a director of the Company, as of the Effective Date.
On May 19, 2026, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.
On May 19, 2026, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.
On May 14, 2026, the Board of Directors (the “Board”) of Duos Technologies Group, Inc. (the “Company”) elected Douglas Recker as a member of the Board, effective immediately.
On February 11, 2026, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “N&CG Committee”), voted to increase the size of the Board from seven members to eight members and to appoint Charles (Chip) R. Romp as a new director to fill the resulting vacancy, effective immediately, for a term extending through the date of the Company’s 2026 Annual Meeting of Stockholders and the election of his successor, or his earlier death, resignation or removal.
On May 15, 2026, the Board appointed Tamara Ward as a member of the Board, effective as of such date.
On May 18, 2026, Mr. Doug Behrens notified Laird Superfood, Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”) of the Company, effective immediately, for personal reasons.
On May 10, 2026, Mohan Ananda notified the Company of his resignation from the Board of Directors of the Company, effective as of May 10, 2026.
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.